Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 822

1.

PhoX: An IMAC-Enrichable Cross-Linking Reagent.

Steigenberger B, Pieters RJ, Heck AJR, Scheltema RA.

ACS Cent Sci. 2019 Sep 25;5(9):1514-1522. doi: 10.1021/acscentsci.9b00416. Epub 2019 Aug 19.

2.

Treatment-related mortality in children with cancer: Prevalence and risk factors.

Loeffen EAH, Knops RRG, Boerhof J, Feijen EAML, Merks JHM, Reedijk AMJ, Lieverst JA, Pieters R, Boezen HM, Kremer LCM, Tissing WJE.

Eur J Cancer. 2019 Sep 27;121:113-122. doi: 10.1016/j.ejca.2019.08.008. [Epub ahead of print]

PMID:
31569066
3.

Visualizing trypanosomes in a vertebrate host reveals novel swimming behaviours, adaptations and attachment mechanisms.

Dóró É, Jacobs SH, Hammond FR, Schipper H, Pieters RP, Carrington M, Wiegertjes GF, Forlenza M.

Elife. 2019 Sep 24;8. pii: e48388. doi: 10.7554/eLife.48388.

4.

Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemia.

Oosterom N, de Jonge R, Smith DEC, Pieters R, Tissing WJE, Fiocco M, van Zelst BD, van den Heuvel-Eibrink MM, Heil SG.

PLoS One. 2019 Sep 17;14(9):e0221591. doi: 10.1371/journal.pone.0221591. eCollection 2019.

5.

A European paediatric cancer mission: aspiration or reality?

Kearns PR, Vassal G, Ladenstein R, Schrappe M, Biondi A, Blanc P, Eggert A, Kienesberger A, Kozhaeva O, Pieters R, Schmiegelow K.

Lancet Oncol. 2019 Sep;20(9):1200-1202. doi: 10.1016/S1470-2045(19)30487-5. No abstract available.

PMID:
31486360
6.

Prevalence and characteristics of incident falls related to nocturnal toileting in hospitalized patients.

Decalf V, Bower W, Rose G, Petrovic M, Pieters R, Eeckloo K, Everaert K.

Acta Clin Belg. 2019 Sep 3:1-6. doi: 10.1080/17843286.2019.1660022. [Epub ahead of print]

PMID:
31478467
7.

The effect of leucovorin rescue therapy on methotrexate-induced oral mucositis in the treatment of paediatric ALL: A systematic review.

Van der Beek JN, Oosterom N, Pieters R, de Jonge R, van den Heuvel-Eibrink MM, Heil SG.

Crit Rev Oncol Hematol. 2019 Oct;142:1-8. doi: 10.1016/j.critrevonc.2019.07.003. Epub 2019 Jul 9. Review.

PMID:
31323533
8.

Reorientation and propulsion in fast-starting zebrafish larvae: an inverse dynamics analysis.

Voesenek CJ, Pieters RPM, Muijres FT, van Leeuwen JL.

J Exp Biol. 2019 Jul 17;222(Pt 14). pii: jeb203091. doi: 10.1242/jeb.203091.

PMID:
31315925
9.

A 'catch-and-release' receptor for the cholera toxin.

Mahon CS, Wildsmith GC, Haksar D, de Poel E, Beekman JM, Pieters RJ, Webb ME, Turnbull WB.

Faraday Discuss. 2019 Jul 17. doi: 10.1039/c9fd00017h. [Epub ahead of print]

PMID:
31313796
10.

Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study.

Pieters R, De Lorenzo P, Ancliffe P, Aversa LA, Brethon B, Biondi A, Campbell M, Escherich G, Ferster A, Gardner RA, Kotecha RS, Lausen B, Li CK, Locatelli F, Attarbaschi A, Peters C, Rubnitz JE, Silverman LB, Stary J, Szczepanski T, Vora A, Schrappe M, Valsecchi MG.

J Clin Oncol. 2019 Sep 1;37(25):2246-2256. doi: 10.1200/JCO.19.00261. Epub 2019 Jul 8.

PMID:
31283407
11.

Enhanced Inhibition of Influenza A Virus Adhesion by Di- and Trivalent Hemagglutinin Inhibitors.

Lu W, Du W, Somovilla VJ, Yu G, Haksar D, de Vries E, Boons GJ, de Vries RP, de Haan CAM, Pieters RJ.

J Med Chem. 2019 Jul 11;62(13):6398-6404. doi: 10.1021/acs.jmedchem.9b00303. Epub 2019 Jun 28.

12.

Temporal variations in turbidity in an oil sands pit lake.

Tedford E, Halferdahl G, Pieters R, Lawrence GA.

Environ Fluid Mech (Dordr). 2019;19(2):457-473. doi: 10.1007/s10652-018-9632-6. Epub 2018 Nov 10.

13.

The effect of asparaginase therapy on methotrexate toxicity and efficacy in children with acute lymphoblastic leukemia.

Kloos RQH, Pieters R, van den Bos C, van Eijkelenburg NKA, de Jonge R, van der Sluis IM.

Leuk Lymphoma. 2019 May 23:1-9. doi: 10.1080/10428194.2019.1613537. [Epub ahead of print]

PMID:
31120351
14.

A network-based approach for identifying suitable biomarkers for oral immunotherapy of food allergy.

van Bilsen JHM, Verschuren L, Wagenaar L, Vonk MM, van Esch BCAM, Knippels LMJ, Garssen J, Smit JJ, Pieters RHH, van den Broek TJ.

BMC Bioinformatics. 2019 Apr 23;20(1):206. doi: 10.1186/s12859-019-2802-9.

15.

Venous thromboembolism in a large cohort of children with acute lymphoblastic leukemia: Risk factors and effect on prognosis.

Klaassen ILM, Lauw MN, Fiocco M, van der Sluis IM, Pieters R, Middeldorp S, van de Wetering MD, de Groot-Kruseman HA, van Ommen CH.

Res Pract Thromb Haemost. 2019 Feb 27;3(2):234-241. doi: 10.1002/rth2.12182. eCollection 2019 Apr.

16.

Non-digestible oligosaccharides scFOS/lcFOS facilitate safe subcutaneous immunotherapy for peanut allergy.

Wagenaar L, van Roest M, Kruijssen LJW, Simons PJ, Boon L, Vonk MM, van Esch BCAM, Knippels LMJ, Garssen J, Pieters RHH, Smit JJ.

Clin Mol Allergy. 2019 Apr 4;17:7. doi: 10.1186/s12948-019-0111-5. eCollection 2019.

17.

Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia.

Steeghs EMP, Boer JM, Hoogkamer AQ, Boeree A, de Haas V, de Groot-Kruseman HA, Horstmann MA, Escherich G, Pieters R, den Boer ML.

Sci Rep. 2019 Mar 15;9(1):4634. doi: 10.1038/s41598-019-41078-4.

18.

NUTM1 is a recurrent fusion gene partner in B-cell precursor acute lymphoblastic leukemia associated with increased expression of genes on chromosome band 10p12.31-12.2.

Hormann FM, Hoogkamer AQ, Beverloo HB, Boeree A, Dingjan I, Wattel MM, Stam RW, Escherich G, Pieters R, den Boer ML, Boer JM.

Haematologica. 2019 Oct;104(10):e455-e459. doi: 10.3324/haematol.2018.206961. Epub 2019 Mar 14. No abstract available.

19.

Mouse strain differences in response to oral immunotherapy for peanut allergy.

Wagenaar L, Bol-Schoenmakers MWHC, Giustarini G, Garssen J, Smit JJ, Pieters RHH.

Immun Inflamm Dis. 2019 Mar;7(1):41-51. doi: 10.1002/iid3.242. Epub 2019 Mar 5.

20.

Butyrate Enhances Desensitization Induced by Oral Immunotherapy in Cow's Milk Allergic Mice.

Vonk MM, Blokhuis BRJ, Diks MAP, Wagenaar L, Smit JJ, Pieters RHH, Garssen J, Knippels LMJ, van Esch BCAM.

Mediators Inflamm. 2019 Jan 16;2019:9062537. doi: 10.1155/2019/9062537. eCollection 2019.

21.

Fibroblast growth factor receptor signaling in pediatric B-cell precursor acute lymphoblastic leukemia.

Jerchel IS, Hoogkamer AQ, Ariës IM, Boer JM, Besselink NJM, Koudijs MJ, Pieters R, den Boer ML.

Sci Rep. 2019 Feb 12;9(1):1875. doi: 10.1038/s41598-018-38169-z.

22.

Study of cross talk between phosphatases and OGA on a ZO-3-derived peptide.

Sharif S, Shi J, Ruijtenbeek R, Pieters RJ.

Amino Acids. 2019 Apr;51(4):739-743. doi: 10.1007/s00726-019-02699-1. Epub 2019 Feb 6.

PMID:
30725225
23.

Carbohydrate-protein interactions and multivalency: implications for the inhibition of influenza A virus infections.

Lu W, Pieters RJ.

Expert Opin Drug Discov. 2019 Apr;14(4):387-395. doi: 10.1080/17460441.2019.1573813. Epub 2019 Feb 5.

PMID:
30722704
24.

Estimating the maximum attachment performance of tree frogs on rough substrates.

Langowski JKA, Rummenie A, Pieters RPM, Kovalev A, Gorb SN, van Leeuwen JL.

Bioinspir Biomim. 2019 Feb 1;14(2):025001. doi: 10.1088/1748-3190/aafc37.

PMID:
30706849
25.

Light-dark rhythms during incubation of broiler chicken embryos and their effects on embryonic and post hatch leg bone development.

van der Pol CW, van Roovert-Reijrink IAM, Maatjens CM, Gussekloo SWS, Kranenbarg S, Wijnen J, Pieters RPM, Schipper H, Kemp B, van den Brand H.

PLoS One. 2019 Jan 25;14(1):e0210886. doi: 10.1371/journal.pone.0210886. eCollection 2019.

26.

Assembly of Divalent Ligands and Their Effect on Divalent Binding to Pseudomonas aeruginosa Lectin LecA.

Yu G, Vicini AC, Pieters RJ.

J Org Chem. 2019 Mar 1;84(5):2470-2488. doi: 10.1021/acs.joc.8b02727. Epub 2019 Feb 11.

27.

Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis.

Agraz-Doblas A, Bueno C, Bashford-Rogers R, Roy A, Schneider P, Bardini M, Ballerini P, Cazzaniga G, Moreno T, Revilla C, Gut M, Valsecchi MG, Roberts I, Pieters R, De Lorenzo P, Varela I, Menendez P, Stam RW.

Haematologica. 2019 Jun;104(6):1176-1188. doi: 10.3324/haematol.2018.206375. Epub 2019 Jan 24.

28.

Biological toxicity estimates show involvement of a wider range of toxic compounds in sediments from Durban, South Africa than indicated from instrumental analyses.

Vogt T, Pieters R, Giesy J, Newman BK.

Mar Pollut Bull. 2019 Jan;138:49-57. doi: 10.1016/j.marpolbul.2018.11.019. Epub 2018 Nov 17.

PMID:
30660298
29.

Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Retrospective Multinational Study.

Pui CH, Rebora P, Schrappe M, Attarbaschi A, Baruchel A, Basso G, Cavé H, Elitzur S, Koh K, Liu HC, Paulsson K, Pieters R, Silverman LB, Stary J, Vora A, Yeoh A, Harrison CJ, Valsecchi MG; Ponte di Legno Childhood ALL Working Group.

J Clin Oncol. 2019 Apr 1;37(10):770-779. doi: 10.1200/JCO.18.00822. Epub 2019 Jan 18.

PMID:
30657737
30.

Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL.

Hamadeh L, Enshaei A, Schwab C, Alonso CN, Attarbaschi A, Barbany G, den Boer ML, Boer JM, Braun M, Dalla Pozza L, Elitzur S, Emerenciano M, Fechina L, Felice MS, Fronkova E, Haltrich I, Heyman MM, Horibe K, Imamura T, Jeison M, Kovács G, Kuiper RP, Mlynarski W, Nebral K, Ivanov Öfverholm I, Pastorczak A, Pieters R, Piko H, Pombo-de-Oliveira MS, Rubio P, Strehl S, Stary J, Sutton R, Trka J, Tsaur G, Venn N, Vora A, Yano M, Harrison CJ, Moorman AV; International BFM Study Group.

Blood Adv. 2019 Jan 22;3(2):148-157. doi: 10.1182/bloodadvances.2018025718.

31.

Lactulose synergizes with CpG-ODN to modulate epithelial and immune cells cross talk.

Mukherjee R, van de Kaa M, Garssen J, Pieters RJ, Kraneveld AD, Willemsen LEM.

Food Funct. 2019 Jan 22;10(1):33-37. doi: 10.1039/c8fo02376j.

PMID:
30632580
32.

Strong Inhibition of Cholera Toxin B Subunit by Affordable, Polymer-Based Multivalent Inhibitors.

Haksar D, de Poel E, van Ufford LQ, Bhatia S, Haag R, Beekman J, Pieters RJ.

Bioconjug Chem. 2019 Mar 20;30(3):785-792. doi: 10.1021/acs.bioconjchem.8b00902. Epub 2019 Jan 24.

33.

'Why us?' Causal attributions of childhood cancer survivors, survivors' parents and community comparisons - a mixed methods analysis.

Vetsch J, Wakefield CE, Doolan EL, Signorelli C, McGill BM, Moore L, Techakesari P, Pieters R, Patenaude AF, McCarthy M, Cohn RJ; ANZCHOG Survivorship Study Group.

Acta Oncol. 2019 Feb;58(2):209-217. doi: 10.1080/0284186X.2018.1532600. Epub 2019 Jan 6.

PMID:
30614350
34.

Fluorescent Trimeric Hemagglutinins Reveal Multivalent Receptor Binding Properties.

Nemanichvili N, Tomris I, Turner HL, McBride R, Grant OC, van der Woude R, Aldosari MH, Pieters RJ, Woods RJ, Paulson JC, Boons GJ, Ward AB, Verheije MH, de Vries RP.

J Mol Biol. 2019 Feb 15;431(4):842-856. doi: 10.1016/j.jmb.2018.12.014. Epub 2018 Dec 29.

35.

Improved survival for children and young adolescents with acute myeloid leukemia: a Dutch study on incidence, survival and mortality.

Reedijk AMJ, Klein K, Coebergh JWW, Kremer LC, Dinmohamed AG, de Haas V, Versluijs AB, Ossenkoppele GJ, Beverloo HB, Pieters R, Zwaan CM, Kaspers GJL, Karim-Kos HE.

Leukemia. 2019 Jun;33(6):1349-1359. doi: 10.1038/s41375-018-0314-7. Epub 2018 Dec 19.

PMID:
30568171
36.

Initial Diagnostic Work-Up of Acute Leukemia: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists and American Society of Hematology Guideline.

de Haas V, Ismaila N, Advani A, Arber DA, Dabney RS, Patel-Donelly D, Kitlas E, Pieters R, Pui CH, Sweet K, Zhang L.

J Clin Oncol. 2019 Jan 20;37(3):239-253. doi: 10.1200/JCO.18.01468. Epub 2018 Dec 3. Erratum in: J Clin Oncol. 2019 Mar 1;37(7):612.

37.

Chemically modified peanut extract shows increased safety while maintaining immunogenicity.

van der Kleij HPM, Warmenhoven HJM, van Ree R, Versteeg SA, Pieters RHH, Dreskin SC, Knulst AC, van Hoffen E, Opstelten DJE, Koppelman SJ, Smit JJ.

Allergy. 2019 May;74(5):986-995. doi: 10.1111/all.13687. Epub 2018 Dec 27.

PMID:
30506686
38.

Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial.

Biondi A, Gandemer V, De Lorenzo P, Cario G, Campbell M, Castor A, Pieters R, Baruchel A, Vora A, Leoni V, Stary J, Escherich G, Li CK, Cazzaniga G, Cavé H, Bradtke J, Conter V, Saha V, Schrappe M, Grazia Valsecchi M.

Lancet Haematol. 2018 Dec;5(12):e641-e652. doi: 10.1016/S2352-3026(18)30173-X.

PMID:
30501871
39.

Understanding physical activity behavior in patients with bladder cancer before and after radical cystectomy: a qualitative interview study.

Rammant E, Fonteyne V, Decaestecker K, Bultijnck R, Deforche B, Pieters R, Ost P, Verhaeghe S, Van Hecke A.

Clin Rehabil. 2019 Apr;33(4):750-761. doi: 10.1177/0269215518815531. Epub 2018 Dec 4.

PMID:
30514109
40.

How I treat infant leukemia.

Brown P, Pieters R, Biondi A.

Blood. 2019 Jan 17;133(3):205-214. doi: 10.1182/blood-2018-04-785980. Epub 2018 Nov 20.

PMID:
30459160
41.

Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia.

Polak R, Bierings MB, van der Leije CS, Sanders MA, Roovers O, Marchante JRM, Boer JM, Cornelissen JJ, Pieters R, den Boer ML, Buitenhuis M.

Haematologica. 2019 Apr;104(4):738-748. doi: 10.3324/haematol.2018.193631. Epub 2018 Oct 31.

42.

Plasma citrulline concentration, a marker for intestinal functionality, reflects exercise intensity in healthy young men.

Kartaram S, Mensink M, Teunis M, Schoen E, Witte G, Janssen Duijghuijsen L, Verschuren M, Mohrmann K, M'Rabet L, Knipping K, Wittink H, van Helvoort A, Garssen J, Witkamp R, Pieters R, van Norren K.

Clin Nutr. 2019 Oct;38(5):2251-2258. doi: 10.1016/j.clnu.2018.09.029. Epub 2018 Sep 28.

PMID:
30340895
43.

Trovafloxacin-Induced Liver Injury: Lack in Regulation of Inflammation by Inhibition of Nucleotide Release and Neutrophil Movement.

Giustarini G, Vrisekoop N, Kruijssen L, Wagenaar L, van Staveren S, van Roest M, Bleumink R, Bol-Schoenmakers M, Weaver RJ, Koenderman L, Smit J, Pieters R.

Toxicol Sci. 2019 Feb 1;167(2):385-396. doi: 10.1093/toxsci/kfy244.

PMID:
30247740
44.

A cost-effectiveness analysis of Erwinia asparaginase therapy in children with acute lymphoblastic leukemia.

Kloos RQH, van Litsenburg RRL, Wolf S, Wismans L, Kaspers GJL, Uyl-de Groot CA, Pieters R, van der Sluis IM.

Pediatr Blood Cancer. 2019 Jan;66(1):e27458. doi: 10.1002/pbc.27458. Epub 2018 Sep 23.

PMID:
30246496
45.

The role of genetic polymorphisms in the thymidylate synthase (TYMS) gene in methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.

Oosterom N, Berrevoets M, den Hoed MAH, Zolk O, Hoerning S, Pluijm SMF, Pieters R, de Jonge R, Tissing WJE, van den Heuvel-Eibrink MM, Heil SG.

Pharmacogenet Genomics. 2018 Oct;28(10):223-229. doi: 10.1097/FPC.0000000000000352.

PMID:
30222710
46.

Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: high white blood cell count at diagnosis is the strongest prognostic factor.

Biondi A, Cario G, De Lorenzo P, Castor A, Conter V, Leoni V, Gandemer V, Pieters R, Stary J, Escherich G, Campbell M, Attarbaschi A, Li CK, Vora A, Bradtke J, Saha V, Valsecchi MG, Schrappe M.

Haematologica. 2019 Jan;104(1):e13-e16. doi: 10.3324/haematol.2018.199422. Epub 2018 Sep 13. No abstract available.

47.

Release of Major Peanut Allergens from Their Matrix under Various pH and Simulated Saliva Conditions-Ara h2 and Ara h6 Are Readily Bio-Accessible.

Koppelman SJ, Smits M, Tomassen M, de Jong GAH, Baumert J, Taylor SL, Witkamp R, Veldman RJ, Pieters R, Wichers H.

Nutrients. 2018 Sep 11;10(9). pii: E1281. doi: 10.3390/nu10091281.

48.

A phase 1/2, open-label, dose-escalation study of midostaurin in children with relapsed or refractory acute leukaemia.

Zwaan CM, Söderhäll S, Brethon B, Luciani M, Rizzari C, Stam RW, Besse E, Dutreix C, Fagioli F, Ho PA, Dufour C, Pieters R.

Br J Haematol. 2019 May;185(3):623-627. doi: 10.1111/bjh.15593. Epub 2018 Sep 11. No abstract available.

PMID:
30203832
49.

Inhibition of O-GlcNAc transferase (OGT) by peptidic hybrids.

Zhang H, Tomašič T, Shi J, Weiss M, Ruijtenbeek R, Anderluh M, Pieters RJ.

Medchemcomm. 2018 Apr 18;9(5):883-887. doi: 10.1039/c8md00115d. eCollection 2018 May 1.

50.

Orthoester functionalized N-guanidino derivatives of 1,5-dideoxy-1,5-imino-d-xylitol as pH-responsive inhibitors of β-glucocerebrosidase.

Sevšek A, Sastre Toraño J, Quarles van Ufford L, Moret EE, Pieters RJ, Martin NI.

Medchemcomm. 2017 Oct 10;8(11):2050-2054. doi: 10.1039/c7md00480j. eCollection 2017 Nov 1.

Supplemental Content

Loading ...
Support Center